Study highlights how fluorescence imaging benefits cervical and uterine cancer treatment
In recent years, the surgical technique sentinel lymph node biopsy has allowed surgeons to more accurately determine how far cancer has spread while lowering patient side effects.
It has become the standard of care in treating breast cancer, melanoma and vulvar cancers, and MD Anderson surgeons are leading clinical studies to apply the technique to treat other cancers, including cervical, uterine and head and neck cancers....
Quality of life’s role in improving exercise study participation for uterine cancer patients
Certain quality-of-life factors, such as pain and anxiety, have a significant impact on the likelihood of endometrial cancer survivors to...
A less-invasive route to uterine cancer diagnosis
In a study of women with high-grade uterine cancer, researchers at MD Anderson Cancer Center found sentinel lymph node (SLN) mapping accurately...
Treating endometrial, colon cancers by targeting a mutated gene
MD Anderson scientists have discovered mutations in a gene that allow tumors to form and grow.
In this month’s issue of Cancer Cell, Gordon Mills, M.D., Ph.D., and Lydia Cheung, Ph.D., report that mutations on the gene PIK3R1 activate enzymes known as ERK and JNK, which prevent cell death. Tumors form when cells that are genetically programmed to die refuse to do so.
Since its discovery two decades ago, the PIK3R1 gene has...
